NCT01773174 - Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Age | Biotech Hunter

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Venous Thromboembolism

Interventions

DRUG

dabigatran etexilate

age \& weight adjusted equivalent of adult dose

Trial Locations (8)

1160.145.00010 Boehringer Ingelheim Investigational Site, Sacramento

1160.145.00009 Boehringer Ingelheim Investigational Site, Louisville

1160.145.00008 Boehringer Ingelheim Investigational Site, Boston

1160.145.00012 Boehringer Ingelheim Investigational Site, St Louis

1160.145.00007 Boehringer Ingelheim Investigational Site, Newark

1160.145.0006 Boehringer Ingelheim Investigational Site, Pittsburgh

1160.145.00001 Boehringer Ingelheim Investigational Site, Houston

1160.145.00011 Boehringer Ingelheim Investigational Site, Spokane